On the downside, GSK's COVID-19 therapy Xevudy (sotrovimab) saw a slump in demand, with sales falling to £500 million from £1.3 billion in the first quarter of 2022, and GSK is expecting the ...

GSK) announced today that the European Medicines Agency (EMA) has begun reviewing a prefilled syringe form of Shingrix, GSK's vaccine for shingles prevention. This new syringe presentation is ...

GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix for the prevention of shingles.

Between being a radio show host, a lead singer in a touring band, and an avid horseback rider, TV personality Faith Martin is living her best life. There's little downtime in Martin's active day ...

During this conference where the launch of the "Shingrix" vaccine was announced, Engineer Hassan Fahmi General Manager of GSK Egypt, spoke about the importance of introducing the "Shingrix ...

GSK’s fourth-quarter Vaccine sales declined 12% due to lower sales of its RSV vaccine Arexvy and shingles vaccine, Shingrix. Arexvy generated £158 million during the quarter, down 69% year ...

GSK reported Q4 sales of $10.40B ... each impacting full year growth by 1 percentage point. Shingrix sales reached 848 million pounds, down 7% (-4% at constant currency). Also Read: Moderna ...

Breakthrough Adjuvant AB-801 Secures“Bioprocessing Excellence in Taiwan” HonorTAIPEI, Taiwan, March 13, 2025 (GLOBE NEWSWIRE) ...

GSK plc GSK reported fourth-quarter 2024 core ... Sales of the company’s shingles vaccine, Shingrix, fell 4% during the quarter due to lower demand in the U.S. and International markets.

LONDON - GlaxoSmithKline PLC (LSE/NYSE: NYSE:GSK) announced today that the European Medicines Agency (EMA) has begun reviewing a prefilled syringe form of Shingrix, GSK (LON:GSK)'s vaccine for ...